85 related articles for article (PubMed ID: 26637886)
1. Multicenter Phase II Study of Nedaplatin and Irinotecan for Patients with Squamous Cell Carcinoma of the Lung: Thoracic Oncology Research Group 0910.
Yamada K; Saito H; Kondo T; Murakami S; Masuda N; Yamamoto M; Igawa S; Katono K; Takiguchi Y; Iwasawa S; Kurimoto R; Okamoto H; Shimokawa T; Hosomi Y; Takagi Y; Kishi K; Ohba M; Oshita F; Watanabe K
Anticancer Res; 2015 Dec; 35(12):6705-11. PubMed ID: 26637886
[TBL] [Abstract][Full Text] [Related]
2. Comparison of nedaplatin and irinotecan for patients with squamous and nonsquamous cell carcinoma of the lung: meta-analysis of four trials.
Oshita F; Honda T; Murakami S; Kondo T; Saito H; Noda K; Yamada K
J Thorac Oncol; 2011 Jan; 6(1):128-31. PubMed ID: 21150472
[TBL] [Abstract][Full Text] [Related]
3. Phase II study of nedaplatin and irinotecan in patients with extensive small-cell lung cancer.
Oshita F; Sugiura M; Murakami S; Kondo T; Saito H; Yamada K
Cancer Chemother Pharmacol; 2013 Feb; 71(2):345-50. PubMed ID: 23124649
[TBL] [Abstract][Full Text] [Related]
4. Phase I/II study of escalating doses of nedaplatin in combination with irinotecan for advanced non-small-cell lung cancer.
Oshita F; Yamada K; Kato Y; Ikehara M; Noda K; Tanaka G; Nomura I; Suzuki R; Saito H
Cancer Chemother Pharmacol; 2003 Jul; 52(1):73-8. PubMed ID: 12750839
[TBL] [Abstract][Full Text] [Related]
5. Phase II study of nedaplatin and irinotecan followed by gefitinib for elderly patients with unresectable non-small cell lung cancer.
Oshita F; Yamada K; Saito H; Noda K
Cancer Chemother Pharmacol; 2008 Aug; 62(3):465-70. PubMed ID: 17960380
[TBL] [Abstract][Full Text] [Related]
6. Nedaplatin plus docetaxel versus cisplatin plus docetaxel for advanced or relapsed squamous cell carcinoma of the lung (WJOG5208L): a randomised, open-label, phase 3 trial.
Shukuya T; Yamanaka T; Seto T; Daga H; Goto K; Saka H; Sugawara S; Takahashi T; Yokota S; Kaneda H; Kawaguchi T; Nagase S; Oguri T; Iwamoto Y; Nishimura T; Hattori Y; Nakagawa K; Nakanishi Y; Yamamoto N;
Lancet Oncol; 2015 Dec; 16(16):1630-8. PubMed ID: 26522337
[TBL] [Abstract][Full Text] [Related]
7. Nedaplatin and irinotecan with concurrent thoracic radiotherapy followed by docetaxel consolidation in patients with locally advanced non-small cell lung cancer.
Oshita F; Murakami S; Kondo T; Saito H; Yamada K; Nakayama Y
J Exp Ther Oncol; 2017 May; 12(1):17-23. PubMed ID: 28472560
[TBL] [Abstract][Full Text] [Related]
8. [A case of complete resection of a squamous cell lung cancer invading diaphragm after neoadjuvant chemotherapy of nedaplatin and irinotecan].
Yutaka Y; Omasa M; Matsumoto M; Ueda Y; Tomiyama K; Shikuma K; Fukui M; Taki T
Gan To Kagaku Ryoho; 2010 Nov; 37(11):2151-3. PubMed ID: 21084816
[TBL] [Abstract][Full Text] [Related]
9. Nedaplatin and irinotecan in patients with large-cell neuroendocrine carcinoma of the lung.
Kenmotsu Y; Oshita F; Sugiura M; Murakami S; Kondo T; Saito H; Yamada K
Anticancer Res; 2012 Apr; 32(4):1453-6. PubMed ID: 22493385
[TBL] [Abstract][Full Text] [Related]
10. Phase II study of nedaplatin and irinotecan for elderly patients with advanced non-small cell lung cancer.
Oshita F; Yamada K; Saito H; Noda K; Hamanaka N; Ikehara M
J Exp Ther Oncol; 2004 Dec; 4(4):343-8. PubMed ID: 15844664
[TBL] [Abstract][Full Text] [Related]
11. Phase II study of neoadjuvant chemotherapy with irinotecan hydrochloride and nedaplatin followed by radical hysterectomy for bulky stage Ib2 to IIb, cervical squamous cell carcinoma: Japanese Gynecologic Oncology Group study (JGOG 1065).
Yamaguchi S; Nishimura R; Yaegashi N; Kiguchi K; Sugiyama T; Kita T; Kubushiro K; Kokawa K; Hiura M; Mizutani K; Yamamoto K; Takizawa K
Oncol Rep; 2012 Aug; 28(2):487-93. PubMed ID: 22614251
[TBL] [Abstract][Full Text] [Related]
12. Weekly irinotecan and cisplatin in advanced non-small cell lung cancer: a multicenter phase II study.
Jagasia MH; Langer CJ; Johnson DH; Yunus F; Rodgers JS; Schlabach LL; Cohen AG; Shyr Y; Carbone DP; Devore RF
Clin Cancer Res; 2001 Jan; 7(1):68-73. PubMed ID: 11205920
[TBL] [Abstract][Full Text] [Related]
13. Feasible combination chemotherapy with nedaplatin and irinotecan for patients with non-small cell lung cancer and multiple high-risk factors.
Oshita F; Saito H; Yamada K
J Exp Ther Oncol; 2007; 6(3):251-6. PubMed ID: 17552365
[TBL] [Abstract][Full Text] [Related]
14. Nedaplatin and irinotecan for patients with recurrent small cell lung cancer.
Ohe M; Oshita F; Kenmotsu Y; Sugiura M; Murakami S; Kondo T; Saito H; Yamada K
J Exp Ther Oncol; 2012; 10(1):65-9. PubMed ID: 22946345
[TBL] [Abstract][Full Text] [Related]
15. Phase II study of nedaplatin and amrubicin as first-line treatment for advanced squamous cell lung cancer.
Taniguchi H; Yamaguchi H; Dotsu Y; Shimada M; Gyotoku H; Senju H; Takemoto S; Kitazaki T; Fukuda M; Ogawara D; Soda H; Nakatomi K; Sugasaki N; Kinoshita A; Nagashima S; Ikeda T; Nakamura Y; Sakamoto N; Obase Y; Fukuda M; Mukae H
Thorac Cancer; 2019 Sep; 10(9):1764-1769. PubMed ID: 31309738
[TBL] [Abstract][Full Text] [Related]
16. Phase II study of nedaplatin and irinotecan with concurrent thoracic radiotherapy in patients with locally advanced non-small-cell lung cancer.
Oshita F; Ohe M; Honda T; Murakami S; Kondo T; Saito H; Noda K; Yamashita K; Nakayama Y; Yamada K
Br J Cancer; 2010 Oct; 103(9):1325-30. PubMed ID: 20940720
[TBL] [Abstract][Full Text] [Related]
17. A Phase II study of weekly irinotecan and capecitabine in patients with previously treated non-small cell lung cancer.
Han JY; Lee DH; Kim HY; Kim EA; Lee JJ; Ju SY; Shin EH; Lee JS
Clin Cancer Res; 2003 Dec; 9(16 Pt 1):5909-14. PubMed ID: 14676114
[TBL] [Abstract][Full Text] [Related]
18. Results of a European Organization for Research and Treatment of Cancer/Early Clinical Studies Group phase II trial of first-line irinotecan in patients with advanced or recurrent squamous cell carcinoma of the cervix.
Lhommé C; Fumoleau P; Fargeot P; Krakowski Y; Dieras V; Chauvergne J; Vennin P; Rebattu P; Roche H; Misset JL; Lentz MA; Van Glabbeke M; Matthieu-Boué A; Mignard D; Chevallier B
J Clin Oncol; 1999 Oct; 17(10):3136-42. PubMed ID: 10506610
[TBL] [Abstract][Full Text] [Related]
19. Irinotecan and oxaliplatin combination as the first-line treatment for patients with advanced non-small cell lung cancer.
Chang MH; Kim KH; Jun HJ; Kim HS; Yi SY; Uhm JE; Park MJ; Lim DH; Ji SH; Hwang IG; Lee J; Park YH; Ahn JS; Ahn MJ; Park K
Cancer Chemother Pharmacol; 2009 Oct; 64(5):917-24. PubMed ID: 19221753
[TBL] [Abstract][Full Text] [Related]
20. Phase II study of combination therapy with S-1 and irinotecan for advanced non-small cell lung cancer: west Japan thoracic oncology group 3505.
Okamoto I; Nishimura T; Miyazaki M; Yoshioka H; Kubo A; Takeda K; Ebi N; Sugawara S; Katakami N; Fukuoka M; Nakagawa K
Clin Cancer Res; 2008 Aug; 14(16):5250-4. PubMed ID: 18698044
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
